Transfusion in Neonatal Patients: Review of Evidence-Based Guidelines

https://doi.org/10.1016/j.cll.2020.10.002Get rights and content

Section snippets

Key points

  • Transfusion recommendations in neonatal patients are less defined by evidence-based guidelines than those in older children and adults.

  • When making the decision to transfuse a neonate, clinicians should consider physiologic differences of this age group, gestational and postnatal age, congenital disorders, and maternal factors.

  • Anemia and thrombocytopenia are highly prevalent in preterm neonates, and the risks versus benefits of transfusion must be weighed carefully in this vulnerable population.

Term Neonates

When making the decision to transfuse during the neonatal period, it is important to understand fetal and neonatal hematopoiesis. Hemoglobin concentration increases progressively throughout gestation and peaks after birth. Full-term neonates have hemoglobin values of 16 to 17 g/dL at term, which may increase by 1 to 2 g/dL because of placental transfusion at birth and may vary depending on timing of cord clamping. There is a gradual decline in hemoglobin concentration to a nadir of 11 to

Neonatal red blood cell transfusion

RBC transfusion is a critical intervention to increase oxygen-carrying capacity in anemic neonates. In addition to severe anemia, indications for transfusion in the early neonatal period can include acute blood loss, hypotension, hypovolemia, or to improve oxygen-carrying capacity in infants with respiratory failure.14 Although often lifesaving, transfusions also have the potential to cause adverse effects, including hemolytic transfusion reactions, alloimmunization, infections, volume

Thrombocytopenia in Neonates

Thrombocytopenia is common in neonates, and can affect an estimated 1% to 2% of otherwise healthy newborns. Critically ill neonates have an even higher rate of thrombocytopenia, with 20% to 35% having platelets counts of less than 150,000/μL.77 The incidence increases with decreasing gestational age, with approximately 70% of VLBW neonates experiencing thrombocytopenia.77,78 The differential diagnosis of thrombocytopenia in neonates is broad, and includes intrauterine infection, placental

Neonatal plasma transfusion

Plasma transfusion in neonates is often used incorrectly.111, 112, 113, 114, 115, 116 In part, this may be because of the lack of evidence-based guidelines available to guide transfusion of FFP in the pediatric patient population. It is essential to determine the clinical scenarios in neonates that require transfusion of plasma and to differentiate those in which an alternative product, such as a specific factor concentrate, should be used. Of note, in the absence of bleeding, plasma should not

Disclosure

The authors have nothing to disclose.

First page preview

First page preview
Click to open first page preview

References (134)

  • C.J. Hunter et al.

    Inflammatory signaling in NEC: role of NF-kappaB, cytokines and other inflammatory mediators

    Pathophysiology

    (2014)
  • H. Bassan

    Intracranial hemorrhage in the preterm infant: understanding it, preventing it

    Clin Perinatol

    (2009)
  • I.T. Jarjour

    Neurodevelopmental outcome after extreme prematurity: a review of the literature

    Pediatr Neurol

    (2015)
  • E.C. Vamvakas

    Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis

    Transfus Med Rev

    (2005)
  • N. Kekre et al.

    Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?

    Biol Blood Marrow Transplant

    (2013)
  • V. Castle et al.

    Frequency and mechanism of neonatal thrombocytopenia

    J Pediatr

    (1986)
  • S.J. Israels et al.

    Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer

    J Pediatr

    (2001)
  • E. Deschmann et al.

    Primary hemostasis in neonates with thrombocytopenia

    J Pediatr

    (2014)
  • S.F. Fustolo-Gunnink et al.

    Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death

    Blood

    (2019)
  • M. Andrew et al.

    A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants

    J Pediatr

    (1993)
  • F. Ferrer-Marin et al.

    Effects of in vitro adult platelet transfusions on neonatal hemostasis

    J Thromb Haemost

    (2011)
  • P. Cure et al.

    2016 proceedings of the National Heart, Lung, and Blood Institute's scientific priorities in pediatric transfusion medicine

    Transfusion

    (2017)
  • G.J. Levy et al.

    National survey of neonatal transfusion practices: I. Red blood cell therapy

    Pediatrics

    (1993)
  • J. Fabres et al.

    Estimating blood needs for very-low-birth-weight infants

    Transfusion

    (2006)
  • H. Zubairi et al.

    Lead exposure in preterm infants receiving red blood cell transfusions

    Pediatr Res

    (2015)
  • D.J. Kahn et al.

    Inter-NICU variation in rates and management of thrombocytopenia among very low birth-weight infants

    J Perinatol

    (2003)
  • C.D. Josephson et al.

    Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey

    Pediatrics

    (2009)
  • M. Cremer et al.

    Platelet transfusions in neonates: practices in the United States vary significantly from those in Austria, Germany, and Switzerland

    Transfusion

    (2011)
  • S.H. Orkin et al.

    Nathan and Oski's hematology of infancy and childhood

    (2009)
  • S.D. Roseff et al.

    Guidelines for assessing appropriateness of pediatric transfusion

    Transfusion

    (2002)
  • F.D. Oakley et al.

    Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products

    Transfusion

    (2015)
  • S. Vossoughi et al.

    Analysis of pediatric adverse reactions to transfusions

    Transfusion

    (2018)
  • P.D. Carroll et al.

    Evaluating otherwise-discarded umbilical cord blood as a source for a Neonate's complete blood cell count at various time points

    Neonatology

    (2018)
  • R.D. Christensen et al.

    Evidence-based advances in transfusion practice in neonatal intensive care units

    Neonatology

    (2014)
  • H. Rabe et al.

    Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes

    Cochrane Database Syst Rev

    (2019)
  • Committee opinion no. 684: delayed umbilical cord clamping after birth

    Obstet Gynecol

    (2017)
  • O. Andersson et al.

    Effect of delayed vs early umbilical cord clamping on iron status and neurodevelopment at age 12 months: a randomized clinical trial

    JAMA Pediatr

    (2014)
  • M.S. Leslie et al.

    Umbilical cord clamping practices of U.S. obstetricians

    J Neonatal Perinatal Med

    (2018)
  • H. Donato et al.

    Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial

    Pediatrics

    (2000)
  • R.K. Ohls et al.

    A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants

    Pediatrics

    (2013)
  • R.K. Ohls et al.

    Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo

    Pediatrics

    (2014)
  • S.E. Juul et al.

    A randomized trial of erythropoietin for neuroprotection in preterm infants

    N Engl J Med

    (2020)
  • S.E. Juul et al.

    Effect of high-dose erythropoietin on blood transfusions in extremely low gestational age neonates: post hoc analysis of a randomized clinical trial

    JAMA Pediatr

    (2020)
  • R.J. Mills et al.

    Enteral iron supplementation in preterm and low birth weight infants

    Cochrane Database Syst Rev

    (2012)
  • R.M. Patel et al.

    Enteral iron supplementation, red blood cell transfusion, and risk of bronchopulmonary dysplasia in very-low-birth-weight infants

    Transfusion

    (2019)
  • S. Ghirardello et al.

    Effects of red blood cell transfusions on the risk of developing complications or death: an observational study of a cohort of very low birth weight infants

    Am J Perinatol

    (2017)
  • A. Keir et al.

    Adverse effects of red blood cell transfusions in neonates: a systematic review and meta-analysis

    Transfusion

    (2016)
  • V.T. Le et al.

    Transient effects of transfusion and feeding advances (volumetric and caloric) on necrotizing enterocolitis development: a case-crossover study

    PLoS One

    (2017)
  • J. Jacob et al.

    Etiologies of NICU deaths

    Pediatrics

    (2015)
  • A. Mohamed et al.

    Transfusion associated necrotizing enterocolitis: a meta-analysis of observational data

    Pediatrics

    (2012)
  • Cited by (14)

    • Patient Blood Management in Neonates

      2023, Clinics in Perinatology
    • Fresh frozen plasma transfusion in the neonatal population: A systematic review

      2022, Blood Reviews
      Citation Excerpt :

      These results demonstrate the prevalence of FFP transfusion differs widely across centers globally. Despite international guidelines [1,4,24,25], FFP transfusions in NICUs are a common practice mainly based on expert opinion. Our search retrieved 17 studies (Table 2), presenting the heterogeneity of FFP transfusion patterns worldwide.

    View all citing articles on Scopus

    Funding: This work was supported in part by funding from P01 HL046925 to C. Josephson. Additional funding was from the NICHD Child Health Research Career Development Award Program, K12HD072245, Atlanta Pediatric Scholars Program to P.E. Zerra.

    View full text